I agree that this site is using cookies. You can find further informations here.
X
Jacqmin, P
226  results:
Search for persons X
?
1

On Fibrations Between Internal Groupoids and Their Normaliz..:

Jacqmin, P.-A. ; Mantovani, S. ; Metere, G..
Applied Categorical Structures.  26 (2018)  5 - p. 1015-1039 , 2018
Link: https://doi.org/10.1007/..
 
?
2

Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 ..:

Monnet, E ; Lapeyre, G ; Poelgeest, E van...
Clinical Pharmacology & Therapeutics.  101 (2016)  2 - p. 200-208 , 2016
Link: https://doi.org/10.1002/..
 
?
3

Assessment of Maraviroc Exposure–Response Relationship at 4..:

Jacqmin, P ; Wade, JR ; Weatherley, B...
CPT: Pharmacometrics & Systems Pharmacology.  2 (2013)  8 - p. 1-9 , 2013
Link: https://doi.org/10.1038/..
 
?
4

Modeling Alzheimer's Disease Progression Using Disease Onse..:

Delor, I ; Charoin, J‐E ; Gieschke, R...
CPT: Pharmacometrics & Systems Pharmacology.  2 (2013)  10 - p. 1-10 , 2013
Link: https://doi.org/10.1038/..
 
?
5

A Comprehensive Hepatitis C Viral Kinetic Model Explaining ..:

Snoeck, E ; Chanu, P ; Lavielle, M...
Clinical Pharmacology & Therapeutics.  87 (2010)  6 - p. 706-713 , 2010
Link: https://doi.org/10.1038/..
 
?
6

PI-47Levetiracetam population pharmacokinetics in children ..:

TOUBLANC, N ; JACQMIN, P ; SARGENTINIMAIER, M.
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P19-P19 , 2006
Link: https://doi.org/10.1016/..
 
?
7

PII-55Retrospective population pharmacokinetic analysis of ..:

PIGEOLET, E ; JACQMIN, P ; SARGENTINIMAIER, M.
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P50-P50 , 2006
Link: https://doi.org/10.1016/..
 
?
8

Modelling Response Time Profiles in the Absence of Drug Con..:

Jacqmin, P. ; Snoeck, E. ; van Schaick, E.A....
Journal of Pharmacokinetics and Pharmacodynamics.  34 (2006)  1 - p. 57-85 , 2006
Link: https://doi.org/10.1007/..
 
?
9

A pharmacokinetic-pharmacodynamic disease model to predict ..:

ROSARIO, M ; JACQMIN, P ; DORR, P..
Clinical Pharmacology & Therapeutics.  78 (2005)  5 - p. 508-519 , 2005
Link: https://doi.org/10.1016/..
 
?
10

Population analysis of the non-linear red blood cell partit..:

Snoeck, E. ; Piotrovskij, V. ; Jacqmin, P....
European Journal of Clinical Pharmacology.  53 (1997)  1 - p. 57-63 , 1997
Link: https://doi.org/10.1007/..
 
?
11

Population analysis of the non linear red blood cell partit..:

Snoeck, E. ; Piotrovskij, V. ; Jacqmin, P....
British Journal of Clinical Pharmacology.  43 (1997)  6 - p. 603-612 , 1997
Link: https://doi.org/10.1046/..
 
?
12

A study of lactate metabolism without tracer during passive..:

Francaux, M. ; Jacqmin, P. ; de Welle, J. Michotte.
European Journal of Applied Physiology and Occupational Physiology.  72 (1995)  1-2 - p. 58-66 , 1995
Link: https://doi.org/10.1007/..
 
?
13

Comparison of gas—liquid chromatography and fluorescence po..:

Stas, C.M. ; Jacqmin, P.A. ; Pellegrin, P.L.
Journal of Pharmaceutical and Biomedical Analysis.  7 (1989)  12 - p. 1651-1656 , 1989
Link: https://doi.org/10.1016/..
 
?
14

Emapalumab in children with primary hemophagocytic lymphohi..:

Locatelli F ; Jordan M. B ; Allen C...
info:eu-repo/semantics/altIdentifier/pmid/32374962.  , 2020
Link: http://hdl.handle.net/23..
 
?
15

Emapalumab in children with primary hemophagocytic lymphohi..:

Locatelli F ; Jordan M. B ; Allen C...
info:eu-repo/semantics/altIdentifier/pmid/32374962.  , 2020
Link: http://hdl.handle.net/11..
 
1-15